Corneal Opacity: Cell Biological Determinants of the Transition From Transparency to Transient Haze to Scarring Fibrosis, and Resolution, After Injury.
Wilson SE, Sampaio LP, Shiju TM, Hilgert GSL, de Oliveira RC.
Invest Ophthalmol Vis Sci. 2022 Jan 3;63(1):22. doi: 10.1167/iovs.63.1.22.
Topical losartan inhibits corneal scarring fibrosis and collagen type IV deposition after Descemet's membrane-endothelial excision in rabbits.
Sampaio LP, Hilgert GSL, Shiju TM, Murillo SE, Santhiago MR, Wilson SE.
Exp Eye Res. 2022 Mar;216:108940. doi: 10.1016/j.exer.2022.108940. Epub 2022 Jan 21.
Trachoma.
Wright HR, Turner A, Taylor HR.
Lancet. 2008 Jun 7;371(9628):1945-54. doi: 10.1016/S0140-6736(08)60836-3.
Repurposing verteporfin and hyaluronic acid gel for ocular surface treatment to prevent corneal scarring.
Chen F, Kang NW, Wungcharoen T, Jiang L, Basco CA, Garcia-Sanchez J, Lin D, Seo YA, Jang K, Myung D, Liu WW.
J Control Release. 2025 Apr 10;380:1141-1151. doi: 10.1016/j.jconrel.2025.02.051. Epub 2025 Feb 27.
Topical Losartan for Treating Corneal Fibrosis (Haze): First Clinical Experience.
Pereira-Souza AL, Ambrósio R Jr, Bandeira F, Salomão MQ, Souza Lima A, Wilson SE.
J Refract Surg. 2022 Nov;38(11):741-746. doi: 10.3928/1081597X-20221018-02. Epub 2022 Nov 1.
Utility of nanomedicine targeting scar-forming myofibroblasts to attenuate corneal scarring and haze.
Ibrahim Al-Mashahedah AM, Kanwar RK, Kanwar JR.
Nanomedicine (Lond). 2019 Apr;14(8):1049-1072. doi: 10.2217/nnm-2017-0305. Epub 2019 Mar 22.
Regenerative Therapy for Corneal Scarring Disorders.
Chandran C, Santra M, Rubin E, Geary ML, Yam GH.
Biomedicines. 2024 Mar 14;12(3):649. doi: 10.3390/biomedicines12030649.
Localised corneal haze and scarring following pulsed accelerated collagen cross-linking for keratoconus.
Said DG, Ross AR, Messina M, Mohammed I, Dua HS.
Eye (Lond). 2019 Jan;33(1):167-168. doi: 10.1038/s41433-018-0211-3. Epub 2018 Sep 24.
Anti-Angiogenic and Anti-Scarring Dual Effect of Galectin-3 Inhibition in Mouse Models of Corneal Wound Healing.
Cao Z, Ramadan A, Tai A, Zetterberg F, Panjwani N.
Am J Pathol. 2024 Mar;194(3):447-458. doi: 10.1016/j.ajpath.2023.11.018. Epub 2023 Dec 28.
Topical Losartan and Corticosteroid Additively Inhibit Corneal Stromal Myofibroblast Generation and Scarring Fibrosis After Alkali Burn Injury.
Sampaio LP, Hilgert GSL, Shiju TM, Santhiago MR, Wilson SE.
Transl Vis Sci Technol. 2022 Jul 8;11(7):9. doi: 10.1167/tvst.11.7.9.
